Growth Capital Firm Profile
In the last 3 years, Vivo Capital has invested in 2 companies.
Vivo Capital’s most common sectors for investment arelife science (73%) and medical products (28%) . The Firm’s most common investment types include venture (73%) and pipe (12%). In total, Vivo Capital has invested in 7 US states and 4 different countries.
In the last 3 years, Vivo Capital has exited 3 companies. The Firm’s most common exit type is ipo (67%). Vivo Capital’s largest (disclosed) exit occurred in 2022 when it sold Sierra Oncology for $2.9B.
Join Mergr to view Vivo Capital’s full profile and discover more mega-sized growth capital firm investors just like it.
M&A Summary
-
M&A Total Activity30
- M&A Buy Activity18
- M&A Sell Activity12
- Total Sectors Invested 2
- Total Countries Invested 4
- M&A Buy/Sell Connections 9
- M&A Advisors 1